Tag: iShares Biotechnology ETF

Jim Cramer says this former Covid market darling is finally investable again

Biotech IPO window is opening but big pharma M&A still sets the pace, top bankers tell CNBC

Drugmakers race to find a place in the next wave of obesity drugs

GSK in talks to acquire Nuvalent for more than $9 billion in biggest deal in over a decade: FT

‘Buying stuff like it’s going out of fashion’: Biotech M&A on track for best year since pre-Covid

Bristol Myers Squibb turns to China to develop new drugs in newest cross-continent collaboration

Hantavirus cases spark surge in pharma and biotech stocks — here’s why

Pharma bets a little-known form of cholesterol will underpin its next blockbuster heart drugs

Eli Lilly agrees to acquire cancer drug maker Kelonia in deal worth up to $7 billion

Trump policies, China’s biotech boom are ending Europe’s pharma powerhouse era